Ermenegildo Arnoldi

Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.

Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 03, 2023

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association.

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association.

Journal: ESMO open

Published: August 22, 2020

Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.

Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.

Journal: The oncologist

Published: July 03, 2020

A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab.

A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 26, 2020

Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.

Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.

Journal: Tumori

Published: February 12, 2020

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Journal: The oncologist

Published: December 22, 2017

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.

Journal: BMC cancer

Published: September 14, 2017

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM).

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM).

Journal: ESMO open

Published: December 22, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026